Skip to content

Clinical trials

Completed Phase 3 Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 3 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20026
20031
20062
20072
20081
20091
20111
20131
20151
20162
20172
20181
20194
20202
20214
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology4
Hoffmann-La Roche4
GlaxoSmithKline3
Case Comprehensive Cancer Center2
Eli Lilly and Company2
PharmaMar2
AbbVie1
Amgen1
AstraZeneca1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma46
Lung Neoplasms13
Carcinoma, Non-Small-Cell Lung7
Breast Neoplasms4
Esophageal Neoplasms3
Neoplasms3
Prostatic Neoplasms3
Bile Duct Neoplasms2
Burkitt Lymphoma2
Colonic Neoplasms2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.